NCT00296361View on ClinicalTrials.gov

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

PHASE3CompletedINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Kidney Transplantation
Interventions
DRUG

Tacrolimus

immunosuppression

Trial Locations (59)

1090

Vienna

Brussels

1200

Brussels

3000

Leuven

4012

Debrecen

4015

Linz

4020

Linz

11009

Cadiz

14004

Córdoba

15706

Santiago de Compostela

18057

Rostock

20132

Milan

20246

Hamburg

21079

Dijon

28007

Madrid

28046

Madrid

29010

Málaga

29200

Brest

30625

Hanover

31059

Toulouse

34346

Hannoversch Münden

39008

Santander

41345

Gothenburg

44892

Bochum

46009

Valencia

46017

Valencia

47011

Valladolid

48149

Münster

50931

Cologne

51109

Cologne

52074

Aachen

70852

Ostrava

75018

Paris

75475

Paris

75970

Paris

79106

Freiburg im Breisgau

80131

Napoli

80480

Amiens

87042

Limoges

93042

Regensburg

Unknown

Nedlands

Perth

775 00

Olomouc

06120

Halle

3015 GD

Rotterdam

80-211

Gdansk

31-501

Krakow

60-479

Poznan

71-455

Szczecin

02-507

Warsaw

50-417

Wroclaw

022328

Bucharest

03010

Alicante

08916

Badalona-Barcelona

08035

Barcelona

08036

Barcelona

07014

Palma de Mallorca

E1 1BB

London

NG5 1PB

Nottingham

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY